| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | IGv | 6.86e-03 | 75 | 31 | 2 | SM00406 | |
| Domain | SPRY | 9.14e-03 | 87 | 31 | 2 | SM00449 | |
| Domain | SPRY | 1.06e-02 | 94 | 31 | 2 | PF00622 | |
| Domain | SPRY_dom | 1.06e-02 | 94 | 31 | 2 | IPR003877 | |
| Domain | B30.2/SPRY | 1.08e-02 | 95 | 31 | 2 | IPR001870 | |
| Domain | B302_SPRY | 1.08e-02 | 95 | 31 | 2 | PS50188 | |
| Pubmed | Control of a neuronal morphology program by an RNA-binding zinc finger protein, Unkempt. | 6.40e-06 | 271 | 34 | 5 | 25737280 | |
| Pubmed | Par3 is essential for the establishment of planar cell polarity of inner ear hair cells. | 2.53e-04 | 24 | 34 | 2 | 30814219 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 5.70e-04 | 1082 | 34 | 6 | 38697112 | |
| Cytoband | 14q32.33 | 6.46e-04 | 228 | 34 | 3 | 14q32.33 | |
| Cytoband | 19q13.12 | 1.32e-03 | 72 | 34 | 2 | 19q13.12 | |
| Cytoband | 11q23.3 | 1.54e-03 | 78 | 34 | 2 | 11q23.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr20p12 | 3.60e-03 | 120 | 34 | 2 | chr20p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p13 | 4.86e-03 | 140 | 34 | 2 | chr2p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q23 | 1.16e-02 | 220 | 34 | 2 | chr11q23 | |
| GeneFamily | Immunoglobulin heavy locus at 14q32.33 | 9.34e-04 | 187 | 19 | 3 | 349 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 1.25e-02 | 163 | 19 | 2 | 590 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A4_(IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.35e-09 | 182 | 32 | 6 | be32b5b8153c1053cbb55f1fccfa27c3ee97c1e1 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.87e-07 | 198 | 32 | 5 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-3|TCGA-Lung / Sample_Type by Project: Shred V9 | 8.90e-06 | 184 | 32 | 4 | ea4ccebe2d54279fcc517e4f0bfa652b91a808bb | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.07e-05 | 193 | 32 | 4 | 315840bc48899f3a36d57b19197509de19716e3d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.14e-05 | 196 | 32 | 4 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.19e-05 | 198 | 32 | 4 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.19e-05 | 198 | 32 | 4 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.19e-05 | 198 | 32 | 4 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.24e-05 | 200 | 32 | 4 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-04 | 132 | 32 | 3 | 97e7d5f7086c6213aec4eaa581bc182338189029 | |
| ToppCell | TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Epitheliod-3|TCGA-Mesothelium / Sample_Type by Project: Shred V9 | 1.28e-04 | 137 | 32 | 3 | a1e34ebbeda3d5a4f14917282d44fcb4dcbf3133 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.65e-04 | 149 | 32 | 3 | 24a7538b54b2a5291503c7493fefed4e45e8d710 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.65e-04 | 149 | 32 | 3 | cc6224c6b79f43b97adc1ce48ca4906bff2ad318 | |
| ToppCell | MS-CD8-CD8_2|MS / Condition, Cell_class and T cell subcluster | 1.68e-04 | 150 | 32 | 3 | 01c20d787ce269db0d153e63a600a8d9ead61856 | |
| ToppCell | mild_COVID-19_(asymptomatic)-NK_CD56bright|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.71e-04 | 151 | 32 | 3 | 2470162f4b56bc505db166a6eb0fa54847759df8 | |
| ToppCell | severe_COVID-19-NK_CD56bright|World / disease group, cell group and cell class (v2) | 1.74e-04 | 152 | 32 | 3 | ab5a4e47b23d16018642d4c9c7f41b30205edf73 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_B-GC_B_(II)|lymph-node_spleen / Manually curated celltypes from each tissue | 1.74e-04 | 152 | 32 | 3 | 4f690aed23338687bdefc47e8a2f3d1fdb2b6447 | |
| ToppCell | mild_COVID-19_(asymptomatic)-NK_CD56bright|World / disease group, cell group and cell class (v2) | 1.78e-04 | 153 | 32 | 3 | aff5c8ab1fb4ebc324cec02cf562b7484bb10db8 | |
| ToppCell | facs-Brain_Myeloid-Cortex-24m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-04 | 154 | 32 | 3 | 1e088b0d4a44267f46a9b643f46a1aba784686b1 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.88e-04 | 156 | 32 | 3 | 60f1ce38e34b582f589db1e0d6139282c1902b2b | |
| ToppCell | severe_COVID-19-NK_CD56bright|severe_COVID-19 / disease group, cell group and cell class (v2) | 1.96e-04 | 158 | 32 | 3 | c2e8d96fc29aa2388b92b4fd81d2726e1f7a053f | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-04 | 160 | 32 | 3 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-04 | 160 | 32 | 3 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.10e-04 | 162 | 32 | 3 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-04 | 165 | 32 | 3 | 11227bff52eed30b80937fdb1968d0b8e6d30365 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-IM|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.22e-04 | 165 | 32 | 3 | fe2135fdacf3807eb4b5ea5e790febfb8cd54335 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.22e-04 | 165 | 32 | 3 | 47e716ce8dc283d406352c1909e09362fcb9e3a3 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-04 | 165 | 32 | 3 | 036f9749048e5e50769cc3210339bf4da469215d | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-04 | 170 | 32 | 3 | 6e82e41acd1299aa549a32ac036b39754abdf376 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-04 | 170 | 32 | 3 | 18cd941bf3ca7cc0b6af1317bd2619d283353de0 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-neuro-epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.55e-04 | 173 | 32 | 3 | 30fa8c14c8a1f546f380132c0c28a61e6a2f9fc4 | |
| ToppCell | droplet-Fat-Scat-21m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-04 | 173 | 32 | 3 | f13124b4cf2ac1dc2895f90f5487d6ac681b0ba4 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_LINC01474|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.64e-04 | 175 | 32 | 3 | 030f93af5a96848b9118e2a8116e19ddae438d92 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.64e-04 | 175 | 32 | 3 | 182e45f5c02214d6b9f317ff5dc43af8b42de978 | |
| ToppCell | ILEUM-inflamed-(3)_pDC|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.69e-04 | 176 | 32 | 3 | b9f847dd55703e413f3cd815eef5724fffaf13b3 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_LINC01474|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.78e-04 | 178 | 32 | 3 | 5522b179c2e7dd707de01e2df10556349d0382a6 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_LINC01474|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.78e-04 | 178 | 32 | 3 | f7f88879a05b2b5fa92cf5317b76f7a3064d1358 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.96e-04 | 182 | 32 | 3 | fa16e194f04250149c82e86551270b244cbc8af4 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.01e-04 | 183 | 32 | 3 | b5d041d0a3506c33de72bf14fa0443f4410fddf1 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.01e-04 | 183 | 32 | 3 | 274076a0978bce2bd53a1732045f18ef0f2d9985 | |
| ToppCell | tumor_Lung-Fibroblasts-Mesothelial_cells|tumor_Lung / Location, Cell class and cell subclass | 3.06e-04 | 184 | 32 | 3 | b0a251030d127858e68cf164be158f209a4d720f | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.11e-04 | 185 | 32 | 3 | 110d5f02759c8235b14aea524ea47199696094ea | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.36e-04 | 190 | 32 | 3 | 91ba66d4b56c59523485b17738e93f14bb00afa4 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.36e-04 | 190 | 32 | 3 | bb3b396d78887d5d6f93a05c8ed4d703591bf33f | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-04 | 190 | 32 | 3 | c03c735a0ed850bf460a1847f5e2dd61753e577d | |
| ToppCell | 15-Trachea-Epithelial-Neuroendocrine|Trachea / Age, Tissue, Lineage and Cell class | 3.41e-04 | 191 | 32 | 3 | 76311fa5f3ae9bb27cf04387a8c92300f2888c28 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.52e-04 | 193 | 32 | 3 | a189d46c39067b717509cd144e0225cc93d7731d | |
| ToppCell | facs-Thymus-nan-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-04 | 194 | 32 | 3 | f1661f9f2439fca5c1012c693b0744c4e3b90a9b | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-04 | 194 | 32 | 3 | 66c056232ac216780acf4cc8ea325bd8ed1909c9 | |
| ToppCell | facs-Thymus-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-04 | 194 | 32 | 3 | cda1b197efb199330ea7ab25a7cee22cae22589d | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-PNs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.79e-04 | 198 | 32 | 3 | 6408653e956fedb284fa5e69ba8f4d620731f556 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.79e-04 | 198 | 32 | 3 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-ESR1--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.90e-04 | 200 | 32 | 3 | 32231471987dd5647c9f7c430ff62dc366b5aea8 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Mesothelial-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 3.90e-04 | 200 | 32 | 3 | bf50e30d5cafb71c567e89580f62084d2f894170 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Cortical_neuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 3.90e-04 | 200 | 32 | 3 | 68c90376e2779434e4ad8dc6dd3b44baa700e2f4 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.90e-04 | 200 | 32 | 3 | 7a8160e6477708f22e48c609bf8f43f3715dcb03 | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-ESR1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.90e-04 | 200 | 32 | 3 | 82caaee79e697ed4ddea7dd49e99b7abe849604f | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Mesothelial-1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.90e-04 | 200 | 32 | 3 | 5e5ad07679d5dd2ca80249bce9aaf4a95d42187b | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Mesothelial-1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.90e-04 | 200 | 32 | 3 | c800f20adedf4ca736c740510889e92d8bf0ba44 | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-ESR1---L3-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.90e-04 | 200 | 32 | 3 | 622ca21b7949ec3d40e17ea08ce4212bbfb963db | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-ESR1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.90e-04 | 200 | 32 | 3 | 0d559f7d8bfd24bcdc770fe2f3baebfddda9b640 | |
| Disease | neutrophil measurement | 8.43e-04 | 177 | 31 | 3 | EFO_0803548 | |
| Disease | complement factor H-related protein 1 measurement | 1.59e-03 | 56 | 31 | 2 | EFO_0600054 | |
| Disease | Prostatic Neoplasms | 3.78e-03 | 616 | 31 | 4 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 3.78e-03 | 616 | 31 | 4 | C0376358 | |
| Disease | complement factor D measurement | 4.31e-03 | 93 | 31 | 2 | EFO_0020283 | |
| Disease | smoking behavior | 5.41e-03 | 341 | 31 | 3 | EFO_0004318 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QYSGYSYKSGHSRSS | 6 | Q9ULK5 | |
| TTYKGKSSFQTYSDY | 1126 | Q9P2K9 | |
| SPTYKQDKHYGYNSY | 216 | P07858 | |
| TKFHQSIGKHYSSGY | 466 | Q9UBL3 | |
| YYTSAGTYGLDSVKK | 216 | Q96IK5 | |
| GHSKYHYYGIGIKES | 186 | Q8HWS3 | |
| GIKESSAYYHSVYSG | 196 | Q8HWS3 | |
| YSSSSHQYPSGYHKA | 366 | Q9P286 | |
| HMGYYSSYKGTENKL | 311 | Q9UBM8 | |
| SYGKSQHYSSEKSAF | 286 | P53985 | |
| SYDGSNKYYADSVKG | 71 | P0DP03 | |
| SYDGSNKYYADSVKG | 71 | P0DP02 | |
| DYGKLGHGNSSTQKY | 486 | Q15751 | |
| NGYSGGTKVHYAYQT | 416 | Q99784 | |
| QDSYKVHSYYKGSDH | 66 | Q9UM44 | |
| YSHNVTVGYYATKGK | 876 | Q6ZVL6 | |
| GHYYQKSKYDSSVSG | 126 | Q9NX40 | |
| HAYPTAYGGKYSVKT | 436 | Q6E0U4 | |
| YGTLHYFTSNQKGKT | 351 | Q8N1C3 | |
| AKGPHEKYGYNSYLS | 111 | Q6IS24 | |
| SYDGSNKYYADSVKG | 71 | P01768 | |
| KSSYHVEGTGYDTYL | 581 | Q5W0V3 | |
| YMFKYDSTHGRYKGS | 116 | O14556 | |
| YYLKTVGHLEKGGSY | 356 | P54803 | |
| GSGKTTTCSKLAYYY | 111 | P61011 | |
| HYYGYGTKKDYQTAA | 561 | Q5TEA6 | |
| SEHISSSGKKYYYNC | 136 | Q9BTA9 | |
| TYHTYIKASGGYLLS | 781 | Q96J65 | |
| VTVKYYGKASHSASY | 206 | Q8IYS1 | |
| AKGASGDHVYTYSYD | 146 | O95427 | |
| YVSGYKHAGTYDQKV | 201 | O94811 | |
| HYAKSGYGAYTPSSY | 21 | O75604 | |
| SNVIDYGHASKYGYT | 206 | Q14966 | |
| KEAYEHTKAYGYTLG | 4986 | P20929 | |
| KGDYSTKKHVYGNGY | 386 | Q15223 |